ADMA: ADMA Biologics, Inc. Stock

by  •  • Comments Off on ADMA: ADMA Biologics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3,964.74
Enterprise Value ($M) 4,007.57
Book Value ($M) 188.27
Book Value / Share 0.81
Price / Book 21.06
NCAV ($M) 115.56
NCAV / Share 0.50
Price / NCAV 34.31

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.10
Return on Equity (ROE) 0.23

Liquidity (mrq)
Quick Ratio 2.80
Current Ratio 6.87

Balance Sheet (mrq) ($M)
Current Assets 303.69
Assets 376.40
Liabilities 188.13
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
6 days ago 13G/A BlackRock, Inc. 16.40
09-23 13G Millennium Management Llc 0.60 -78.03
03-11 13G/A Nuveen Asset Management, LLC 2.17 -2.77
03-11 13G/A Tiaa Cref Investment Management Llc 2.17 -2.77
03-11 13G/A Teachers Advisors, Llc 2.17 -2.77
02-14 13G/A Perceptive Advisors Llc 2.80 -45.94
02-13 13G Vanguard Group Inc 5.71
01-26 13G/A BlackRock Inc. 7.90 18.65

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-11 1,659,470 8,139,137 20.39
2024-10-10 3,600,549 21,241,718 16.95
2024-10-09 691,295 2,737,441 25.25
2024-10-08 859,515 2,744,085 31.32
2024-10-07 477,185 2,029,549 23.51

(click for more detail)

Similar Companies
ACET – Adicet Bio, Inc. ACIU – AC Immune SA
ACRV – Acrivon Therapeutics, Inc. AFMD – Affimed N.V.
ALT – Altimmune, Inc.


Financial data and stock pages provided by
Fintel.io